Thrivent Financial for Lutherans
ATRA icon

Thrivent Financial for Lutherans’s Atara Biotherapeutics ATRA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,946
Closed -$214K – 2467
2023
Q1 		$214K Hold
2,946
– – ﹤0.01% 2370
2022
Q4 		$241K Hold
2,946
– – ﹤0.01% 2304
2022
Q3 		$279K Hold
2,946
– – ﹤0.01% 2248
2022
Q2 		$573K Buy
+2,946
New +$481K ﹤0.01% 2026
2021
Q2 		– Sell
-1,785
Closed -$641K – 2455
2021
Q1 		$641K Sell
1,785
-1,850
-51% -$818K ﹤0.01% 2129
2020
Q4 		$1.78M Buy
3,635
+1,514
+71% +$699K ﹤0.01% 1389
2020
Q3 		$687K Sell
2,121
-17
-0.8% -$5.79K ﹤0.01% 1806
2020
Q2 		$779K Hold
2,138
– – ﹤0.01% 1666
2020
Q1 		$455K Buy
+2,138
New +$679K ﹤0.01% 1768

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return